15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering ATRenew Inc DRC, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $5.50 to $5.50, so the covering firms are broadly aligned. The average target of $5.50 sits 35% above the current $4.07. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.84 next quarter toward $4.09 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to ATRenew Inc DRC.
12-MONTH PRICE TARGET
$5.50
+35.1% upside
Average analyst target vs $4.07 current
Highest Target$5.50
Average Target$5.50
Lowest Target$5.50
Detailed analyst forecasts for RERE
Showing 1–1 of 1 analyst
Analyst Rating
Upside / Downside
Action
ANALYST
FIRM
PRICE TARGET
RATING
UPSIDE
ACTION
DATE
MLMandy Liu
UBS
$5.50
Buy
+35.1%
Initiates
07/21/26
RERE analyst recommendation trends
86420
Jul
Aug
Sep
Strong BuyBuyHoldSellStrong Sell
RATING
JUL
AUG
SEP
Strong Buy
0
0
0
Buy
1
1
1
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
Total
1
1
1
As of Sep, 1 of 1 firms rate RERE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
RERE EPS & revenue forecast
EPS · NEXT QUARTER
$0.84
Range $0.74 – $0.95 · 2 analysts · +54% YoY
Next period, 2 analysts expect ATRenew Inc DRC to earn $0.84 a share (range $0.74 – $0.95), versus $0.55 a year earlier. Full-year consensus is $2.82, growing to $4.09 the year after.
REVENUE · NEXT QUARTER
$7.6B
Range $7.1B – $7.9B · 2 analysts · +21% YoY
Revenue is expected to reach $7.6B (range $7.1B – $7.9B), +21.3% year-over-year. Full-year consensus is $26.8B, rising to $32.3B next year.
RERE stock forecast FAQ
What is RERE's average 12-month price target?+
The 1 analysts with a live target average $5.50 for ATRenew Inc DRC over the next 12 months, ranging from a $5.50 high to a $5.50 low.
Is RERE stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover RERE?+
1 analysts have an active rating on ATRenew Inc DRC, and 1 firms carry a live 12-month price target.
What is ATRenew Inc DRC's projected EPS for next quarter?+
The consensus estimate is $0.84 per share (range $0.74 – $0.95) across 2 analysts. Full-year EPS is projected at $2.82, rising to $4.09 the following year.
How much revenue is ATRenew Inc DRC expected to report next quarter?+
Consensus revenue is $7.6B (range $7.1B – $7.9B). Full-year revenue is projected at $26.8B, growing to $32.3B next year.
Have analysts been upgrading or downgrading RERE lately?+
As of Sep, 1 of 1 firms rate RERE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RERE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
UBS
